It is generally not recommended to take etoricoxib and benzbromarone at the same time. Etoricoxib is a non-steroidal anti-inflammatory drug, and benzbromarone is a uric acid-lowering drug that promotes uric acid excretion. Benzbromarone can be used for the treatment of hyperuricemia and the intermittent period of gout, while etoricoxib can be used for symptomatic relief of the acute attack of gout. Etoricoxib and other non-steroidal anti-inflammatory drugs can cause renal injury, and benzbromarone can lead to obstructive renal damage. Therefore, concomitant administration of etoricoxib and benzbromarone may increase the risk of kidney injury, and they are used separately for different periods of gout, so concomitant administration of etoricoxib and benzbromarone is generally not recommended. Digestive symptoms such as diarrhea, stomach upset, nausea, and skin allergies such as windburns, maculopapular rash, flushing, and itching may occur with benzbromarone. It is contraindicated in people with moderate to severe renal impairment, pregnant women or women with the possibility of pregnancy, as well as breastfeeding women. Take care to drink plenty of water during the medication. Adverse reactions such as dyspepsia, nausea, allergy may occur with Etoricoxib. It is contraindicated in people with drug hypersensitivity, patients with active peptic ulcers or bleeding. Take care to minimize the duration and dosage of the drug at the effective dose and avoid combining it with other NSAIDs. Etoricoxib and Benzbromarone should be used under the guidance of a physician, it is recommended that patients who need to use these two drugs to the relevant departments of the regular hospital for consultation, do not take the drug on their own.